| Literature DB >> 28411912 |
Miki Haifler1, Alexander Kutikov2.
Abstract
Most small renal masses (SRMs) are indolent. In fact, only approximately 80% of SRMs are malignant. Furthermore, SRMs are commonly detected in elderly and comorbid patients. Therefore, opportunities for better care intensity calibration exist. Renal mass biopsy (RMB), when appropriately used, is a valuable clinical tool to help with critical clinical decision-making in patients with SRM. This article summarizes the role of modern RMB in helping gauge care for patients with SRM.Entities:
Keywords: Accuracy; Biopsy; Diagnosis; Renal cell carcinoma; Renal mass
Mesh:
Year: 2017 PMID: 28411912 DOI: 10.1016/j.ucl.2016.12.006
Source DB: PubMed Journal: Urol Clin North Am ISSN: 0094-0143 Impact factor: 2.241